GB2131292B - Progestational pharmaceutical formulations - Google Patents
Progestational pharmaceutical formulationsInfo
- Publication number
- GB2131292B GB2131292B GB08234226A GB8234226A GB2131292B GB 2131292 B GB2131292 B GB 2131292B GB 08234226 A GB08234226 A GB 08234226A GB 8234226 A GB8234226 A GB 8234226A GB 2131292 B GB2131292 B GB 2131292B
- Authority
- GB
- United Kingdom
- Prior art keywords
- progestational
- pharmaceutical formulations
- formulations
- pharmaceutical
- progestational pharmaceutical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB08234226A GB2131292B (en) | 1982-12-01 | 1982-12-01 | Progestational pharmaceutical formulations |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB08234226A GB2131292B (en) | 1982-12-01 | 1982-12-01 | Progestational pharmaceutical formulations |
Publications (2)
Publication Number | Publication Date |
---|---|
GB2131292A GB2131292A (en) | 1984-06-20 |
GB2131292B true GB2131292B (en) | 1987-03-11 |
Family
ID=10534652
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB08234226A Expired GB2131292B (en) | 1982-12-01 | 1982-12-01 | Progestational pharmaceutical formulations |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB2131292B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3738620A1 (en) * | 1987-11-13 | 1989-05-24 | Luderschmidt Christoph | USE OF ETHISTERONE FOR TOPICAL TREATMENT OF ACNE OR ANDROGENETIC ALOPECIA |
EP2002839A1 (en) * | 1998-04-17 | 2008-12-17 | Ortho McNeil Pharmaceutical, Inc. | Folic acid-containing pharmaceutical compositions, and related methods and delivery systems |
HUP9900213A1 (en) * | 1999-02-01 | 2000-12-28 | Gábor Bogye | Pharmaceutical compositions for diminishing side-effects of gestagene-type hormone-containing compositions |
-
1982
- 1982-12-01 GB GB08234226A patent/GB2131292B/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
GB2131292A (en) | 1984-06-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3378523D1 (en) | Pharmaceutical formulations | |
GB8326565D0 (en) | Pharmaceutical compositions | |
HK16090A (en) | Pharmaceutical compositions | |
ZA833781B (en) | Pharmaceutical compositions | |
EP0093551A3 (en) | Pharmaceutical composition | |
KE3814A (en) | Pharmaceutical formulations | |
GB2118176B (en) | Pharmaceutical compositions | |
GB2117766B (en) | Pharmaceutical compositions | |
GB8324133D0 (en) | Pharmaceutical compositions | |
GB8429749D0 (en) | Pharmaceutical compositions | |
GB8313814D0 (en) | Pharmaceutical compositions | |
DE3377696D1 (en) | Pharmaceutical compositions | |
GB8328896D0 (en) | Pharmaceutical composition | |
US4594359B1 (en) | Pharmaceutical compositions | |
GB2114001B (en) | Nasel pharmaceutical compositions | |
GB2131292B (en) | Progestational pharmaceutical formulations | |
GB8305028D0 (en) | Pharmaceutical compositions | |
GB8314736D0 (en) | Pharmaceutical compositions | |
GB8330810D0 (en) | Pharmaceutical compositions | |
ZA833692B (en) | Pharmaceutical formulations | |
GB8331068D0 (en) | Pharmaceutical compositions | |
GB8329391D0 (en) | Pharmaceutical compositions | |
GB8314540D0 (en) | Pharmaceutical composition | |
IE822854L (en) | Pharmaceutical formulation | |
DE3372706D1 (en) | Pharmaceutical compositions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
732 | Registration of transactions, instruments or events in the register (sect. 32/1977) | ||
PCNP | Patent ceased through non-payment of renewal fee |